To this end, we subcutaneously injected wild type and Emilin2−/− animals with B16F10 syngenic melanoma cells and treated them with an anti-PD-L1 blocking antibody or the isotype control and monitored tumor growth over time (Figure 3A). Here, CD274 is linked to melanoma.